Media headlines about Sientra (NASDAQ:SIEN) have been trending positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sientra earned a media sentiment score of 0.29 on Accern’s scale. Accern also assigned headlines about the medical instruments supplier an impact score of 47.8394779187823 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s analysis:
- Sientra Inc (SIEN) Receives Average Recommendation of “Hold” from Brokerages (americanbankingnews.com)
- Investors Purchase Large Volume of Sientra Call Options (SIEN) (americanbankingnews.com)
- Senzar Asset Management LLC Boosts Holdings in Sientra Inc (SIEN) (americanbankingnews.com)
- Short Interest in Sientra Inc (SIEN) Expands By 38.8% (americanbankingnews.com)
- Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2017 (finance.yahoo.com)
SIEN has been the subject of several recent research reports. BidaskClub downgraded Sientra from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. ValuEngine raised Sientra from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st. Zacks Investment Research raised Sientra from a “sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. Canaccord Genuity reissued a “buy” rating and issued a $19.00 price objective on shares of Sientra in a research note on Friday, January 5th. Finally, Stifel Nicolaus raised Sientra from a “hold” rating to a “buy” rating and set a $14.00 price objective for the company in a research note on Friday, January 19th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $14.00.
TRADEMARK VIOLATION WARNING: “Favorable Press Coverage Somewhat Unlikely to Impact Sientra (SIEN) Share Price” was published by BBNS and is owned by of BBNS. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://baseballnewssource.com/2018/03/09/favorable-press-coverage-somewhat-unlikely-to-impact-sientra-sien-share-price/1991614.html.
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.